Drug factory · FDA FEI 3003688035
Rolabo Outsourcing S.L.
Poligono Industrial Malpica, Calle J, Parcelas 3-4, Zaragoza, Spain
Problems found, fixed voluntarily at FDA's last inspection, Dec 21, 2023.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
6 drug inspections on record since 2011: 2 with no problems, 4 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Canagliflozin and Metformin | Makes the active ingredient | Janssen Pharmaceuticals, Inc. | 50458-940, 50458-941, 50458-942 +1 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Dec 21, 2023 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Oct 29, 2020 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Sep 7, 2018 | No problems found | Drug Quality Assurance | — |
| Jan 21, 2016 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Feb 6, 2014 | No problems found | Drug Quality Assurance | — |
| Jul 28, 2011 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
Registered with FDA for: analysis; api manufacture.